Year All202620252024202320222021202020192018201720162015201420122011 Jul 21, 2025 Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 Jun 2, 2025 Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer May 21, 2025 Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 May 6, 2025 Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference May 1, 2025 Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update Apr 29, 2025 Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors Apr 24, 2025 Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference Apr 17, 2025 Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 Apr 16, 2025 Laura A. Williams, M.D., MPH, Appointed as Chief Patient Officer at Ardelyx Apr 10, 2025 Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings